CYTO Message Board - Msg: 14316295

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYTO

CYTO 0.300

+241.1%

Dec 19 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Oravetz who wrote (7929)	9/1/2000 12:35:33 PM
From: Jim Oravetz	of 8116

Semi-OT:(Proteomics info)Hardware firms ride biotech wave …Advocates say proteomics, identifying proteins in cells, could supply information needed for more practical medical products than gene-sequencing genomics. Complex proteins command bodily functions and the vast majority of all drugs work by interacting with them. ''There is a growing belief that proteomics can be bigger than genomics,'' said Mazar. ''Proteomics should tell you a lot more about disease states than genomics.'' Basic mass spectrometry instruments may run $150,000, but a complete system involving sophsticated computer hardware and software, capable of analyzing thousands of proteins in a blood or tissue sample, can cost nearly $1 million. Researchers spend about $100 million a year on instruments used in proteomics, but some aggressive estimates believe that figure could grow to $1 billion. Waters is not alone in that field, but counts itself among a group of leaders. Who will produce the breakthrough biotech products of the future remains an investor's crap shoot, but every competitor will need to buy the equipment to try. boston.com This is the extent of CYTO related text. Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next